Latest Share Chat

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,583.50

Bid: 1,583.00

Ask: 1,584.00

Change: -34.50 (-2.13%)

Spread: 1.00 (0.063%)

Open: 1,608.00

High: 1,615.00

Low: 1,575.00

Prev. Close: 1,618.00

Last checked at -

UK BROKER RATINGS SUMMARY: HSBC Downgrades BT To Hold From Buy

Fri, 31st Jan 2020 09:31

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

----------

FTSE 100

----------

HSBC CUTS BT GROUP TO 'HOLD' ('BUY') - PRICE TARGET 185 (225) PENCE

----------

BARCLAYS CUTS HARGREAVES LANSDOWN TARGET TO 2070 (2090) PENCE - 'OVERWEIGHT'

----------

BERENBERG CUTS DIAGEO PRICE TARGET TO 2720 (2860) PENCE - 'HOLD'

----------

BERNSTEIN CUTS DIAGEO PRICE TARGET TO 3370 (3400) PENCE - 'MARKET-PERFORM'

----------

UBS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1950 (1900) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES OCADO PRICE TARGET TO 1250 (1220) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ADMIRAL PRICE TARGET TO 1925 (1950) PENCE - 'UNDERWEIGHT'

----------

UBS CUTS SHELL PRICE TARGET TO 2450 (2700) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 2750 (2900) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS SHELL PRICE TARGET TO 2470 (2780) PENCE - 'BUY'

----------

FTSE 250

----------

DEUTSCHE BANK RAISES WIZZ AIR PRICE TARGET TO 4900 (4550) PENCE - 'BUY'

----------

BERENBERG RAISES WIZZ AIR PRICE TARGET TO 4000 (3700) PENCE - 'HOLD'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM CUTS STAFFLINE PRICE TARGET TO 100 (125) PENCE - 'BUY'

----------

LIBERUM RAISES FULLER SMITH & TURNER PRICE TARGET TO 950 (915) PENCE - 'HOLD'

----------

LIBERUM CUTS ON THE BEACH GROUP PRICE TARGET TO 540 (550) PENCE - 'BUY'

----------

More News

17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

8 Jan 2024 23:00

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: HSBC Downgrades BT To Hold From Buy

Login to your account

Quickpicks are a member only feature

Login to your account